Nanoviricides NNVC
NYSE NNVC
$1.41 +0.02 (+1.80%)
As of: Oct 23, 2026 · 3:58 PM EDT

Nanoviricides (NNVC) Revenue (2016 - 2018)

Updated

Analysis

Nanoviricides (NNVC) Revenue (2016 - 2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 25.40 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 16.99 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 15.38 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 7.80 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 15.03 Bn
10 Nanoviricides 28.26 Mn 15.92 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 23,769.00
Dec 31, 2017 24,970.00
Mar 31, 2017 17,959.00
Dec 31, 2016 11,734.00
API Access

Nanoviricides Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=NNVC&period=max&api_key=YOUR_API_KEY